framework contract for the supply of the latest approved protein based COVID-19 vaccines
Buyer: European Commission, DG HERA - European Health Emergency Preparedness and Response Authority
- Published
- 18 November 2025
- Estimated value
- €0
- Procedure
- Negotiated procedure
- Lots
- 1
- Notice number
- 00762535-2025
- Reference
- 8d470656-4544-40e6-8293-45e7a04adadc
- Official source
- Official source
CPV codes
- 33600000Productos farmacéuticos
Description
The subject of this contract is the supply of the latest approved protein based COVID-19 vaccines up to 4,000,000 doses. Throughout the delivery schedule and/or duration of the contract (whichever lasts longer), the contractor shall ensure that the vaccine is adapted to the relevant variants for the European Union population and ensure availability of adapted vaccines in accordance with the most recent Experts recommendations on the need for updating the strain composition of C19 vaccines. The necessity of adapting the vaccine shall be assessed at least yearly, on time, to start timely distribution of updated vaccines for vaccination during second half of the year, unless other timing of updates is considered necessary. The contractor shall also ensure any other relevant changes to the vaccine, as necessary, to address efficacy and safety needs of the product and to enable adequate immunization activities by the participating countries.
Award criteria
- Quality — Please consult the procurement documents.
- Price — Please consult the procurement documents.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| HIPRA HUMAN HEALTH SL | — | — |
| HIPRA SCIENTIFIC SL | — | — |
| LABORATORIOS HIPRA SA | — | — |
Official publications
- TED · 00762535-2025 · 18 November 2025
- OJS · 222/2025 · 18 November 2025
Other tenders from European Commission, DG HERA - European Health Emergency Preparedness and Response Authority
- Framework contract for RSV vaccines
- Procurement of antiviral, Favipiravir 200mg tablets for Andes virus
- Framework contract for supply of Modified Vaccinia Ankara–Bavarian Nordic (MVA-BN®), a third-generation, non-replicating smallpox vaccine
- Framework contract for the reservation and supply of Foclivia
- FWC for the supply of for the supply of mRNA COVID-19 vaccine.
- Framework contract for the supply of Veklury
- Framework contract for RSV vaccines
- framework contract for the supply of the latest approved protein based COVID-19 vaccines
- framework contract for the supply of the latest approved protein based COVID-19 vaccines
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is €0.
- Who is the buyer of this tender?
- The contracting authority is European Commission, DG HERA - European Health Emergency Preparedness and Response Authority (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Create a free account and receive new tenders from European Union matching your business, every day.